Mechanistic Insights into Cardiac Stem Cell Therapy from a Histopathologic Perspective

Introduction Of patients with ST-segment elevation myocardial infarction (STEMI), one-third will die, half of these deaths occurring within 1 hour. Over 36% of patients with a myocardial infarction will show a reduction of myocardial contractile function and develop heart failure.1